|
|
DSpace at RU >
Browsing by Author Mochtar, C.A.
Showing results 1 to 5 of 5
| Full Text | Issue Date | Title | Author(s) | | 2006 | Accurate prediction of need for invasive treatment in alpha1-blocker treated patients with benign prostatic hyperplasia not possible: bootstrap validation analysis. | Kiemeney, L.A.L.M.; Mochtar, C.A.; Straatman, H.M.P.M. |
| 2006 | Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. | Mochtar, C.A.; Kiemeney, L.A.L.M.; Riemsdijk, M.M. van; Laguna, M.P.; Debruyne, F.M.J., et al |
| 2006 | Polymorphisms in the alpha1A-adrenoceptor gene do not modify the short- and long-term efficacy of alpha1-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. | Mochtar, C.A.; Laan, W.; Houwelingen, K.P. van; Franke, B.; Rosette, J.J.M.H.C. de la, et al |
| 2006 | PSA velocity in conservatively managed BPH: can it predict the need for BPH-related invasive therapy? | Mochtar, C.A.; Kiemeney, L.A.L.M.; Laguna, M.P.; Debruyne, F.M.J.; Rosette, J.J.M.H.C. de la |
| 2005 | Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting. | Mochtar, C.A.; Kiemeney, L.A.L.M.; Laguna, P.M.; Riemsdijk, M.M. van; Barnett, G.S., et al |
Showing results 1 to 5 of 5
|